- Recent Funding
- Investors
- Kangyuan Huiying
Kangyuan Huiying portfolio
Kangyuan Huiying has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is GenMedicn Biopharma's Series A round in October 2026, alongside Longmen Capital, Huade Science and Technology, Enran Chuangtou and 1 other. That company is in Health and bio.
What Kangyuan Huiying invests in
- Health and bio · 1 · 100%
How Kangyuan Huiying invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | undisclosed |
Share is of the 1 round on Recent Funding that name Kangyuan Huiying. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Kangyuan Huiying portfolio companies
GGenMedicn BiopharmaSeries A · Oct 2026
| Company | Round with Kangyuan Huiying | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A | undisclosed | Oct 7, 2026 Series A |
Most frequent co-investors
LLongmen Capital1 shared round · last Oct 7, 2026
- HHuade Science and Technology1 shared round · last Oct 7, 2026
EEnran Chuangtou1 shared round · last Oct 7, 2026
- BBroadcom Capital1 shared round · last Oct 7, 2026
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moFFirst Imagine!1 company · 1 deal in 12 mo
MMaxis1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Kangyuan Huiying, which is a subset of its real portfolio. API: /api/v1/investors/kangyuan-huiying (get a free API key). More: the most active VC firms and new venture capital funds.